logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11351148 B1

PDFFull Text
Date of Patent:
Jun. 07, 2022

Filed:

Dec. 28, 2021

Pharmaceutical composition mix a to treat health conditions associated with elevated glucose levels

Applicant:

Matthias W Rath, Henderson, NV (US);

Inventors:

Madhurima Chatterjee, Santa Clara, CA (US);

Matthias W Rath, Aptos, CA (US);

Aleksandra Niedzwiecki, Aptos, CA (US);

Anna Goc, San Jose, CA (US);

Assignee:

Other;

Attorneys:

Geeta Kadambi

Riddhi IP LLC

Primary Examiner:

Ernst V Arnold

Int. Cl.
CPC ...
A61K 31/07 (2006.01); A61K 31/51 (2006.01); A61K 33/00 (2006.01); A61K 33/06 (2006.01); A61K 33/30 (2006.01); A61K 36/54 (2006.01); A61K 36/87 (2006.01); A61K 31/375 (2006.01); A61K 31/714 (2006.01); A61K 31/355 (2006.01); A61K 31/593 (2006.01); A61K 31/197 (2006.01); A61K 31/455 (2006.01); A61K 36/282 (2006.01); A61K 31/385 (2006.01); A61K 31/7004 (2006.01); A61K 31/4415 (2006.01); A61K 31/519 (2006.01); A61K 36/82 (2006.01); A61K 31/122 (2006.01); A61K 33/18 (2006.01); A61K 33/32 (2006.01); A61K 31/525 (2006.01); A61K 33/22 (2006.01); A61K 36/61 (2006.01); A61K 31/047 (2006.01); A61K 31/4188 (2006.01); A61K 31/198 (2006.01); A61K 31/575 (2006.01); A61K 36/185 (2006.01); A61K 31/7084 (2006.01);
U.S. Cl.
CPC ...
A61K 31/375 (2013.01); A61K 31/047 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/355 (2013.01); A61K 31/385 (2013.01); A61K 31/4188 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/575 (2013.01); A61K 31/593 (2013.01); A61K 31/7004 (2013.01); A61K 31/7084 (2013.01); A61K 31/714 (2013.01); A61K 33/00 (2013.01); A61K 33/06 (2013.01); A61K 33/18 (2013.01); A61K 33/22 (2013.01); A61K 33/30 (2013.01); A61K 33/32 (2013.01); A61K 36/185 (2013.01); A61K 36/282 (2013.01); A61K 36/54 (2013.01); A61K 36/61 (2013.01); A61K 36/82 (2013.01); A61K 36/87 (2013.01);
Abstract

A threefold decrease in α-amylase inhibition, increase in insulin secretion and glucose uptake increase by the pharmaceutical composition of several naturally occurring substances and vitamins were observed when compared to the control cells, and a c.a. 1-1.5 fold decrease when compared to the positive control. More specifically Mix A shows significant effect on increased insulin secretion and glucose uptake by cells.

Find Patent Forward Citations

Chatterjee, Madhurima. (2022). Pharmaceutical composition mix a to treat health conditions associated with elevated glucose levels (U.S. Patent No. 11351148). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11351148

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…